The literature surrounding breast and colorectal cancer prognosis in relation to ODC1 expression is not conclusive [8,32,33,34,35], whereas in neuroblastoma it is well established that high ODC1 mRNA expression is associated with poor outcome [10,11,13]. This evidence concerns the gene ODC1 and colorectal cancer.